Bcl-xL Is Spontaneously Inserted into Preassembled Nanodiscs and Stimulates Bax Insertion in a Cell-Free Protein Synthesis System

Biomolecules. 2023 May 23;13(6):876. doi: 10.3390/biom13060876.

Abstract

The antiapoptotic protein Bcl-xL is a major regulator of cell death and survival, but many aspects of its functions remain elusive. It is mostly localized in the mitochondrial outer membrane (MOM) owing to its C-terminal hydrophobic α-helix. In order to gain further information about its membrane organization, we set up a model system combining cell-free protein synthesis and nanodisc insertion. We found that, contrary to its proapoptotic partner Bax, neosynthesized Bcl-xL was spontaneously inserted into nanodiscs. The deletion of the C-terminal α-helix of Bcl-xL prevented nanodisc insertion. We also found that nanodisc insertion protected Bcl-xL against the proteolysis of the 13 C-terminal residues that occurs during expression of Bcl-xL as a soluble protein in E. coli. Interestingly, we observed that Bcl-xL increased the insertion of Bax into nanodiscs, in a similar way to that which occurs in mitochondria. Cell-free synthesis in the presence of nanodiscs is, thus, a suitable model system to study the molecular aspects of the interaction between Bcl-xL and Bax during their membrane insertion.

Keywords: Bax; Bcl-xL; MALDI; apoptosis; cell-free synthesis; membrane insertion; nanodiscs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis Regulatory Proteins
  • Apoptosis*
  • Escherichia coli* / genetics
  • Escherichia coli* / metabolism
  • bcl-2-Associated X Protein / genetics
  • bcl-2-Associated X Protein / metabolism
  • bcl-X Protein / genetics

Substances

  • bcl-2-Associated X Protein
  • bcl-X Protein
  • Apoptosis Regulatory Proteins

Grants and funding

This research was funded by the Centre National de la Recherche Scientifique, the Université de Bordeaux (SBM department AO3, to S.M. and S.C.), the Agence Nationale pour la Recherche (WrinXL to M.P.), and the Ligue Régionale contre le Cancer, comité Gironde (LS 249487 to S.M.). A.R.E. is recipient of a PhD fellowship from the Agence Nationale des Bourses du Gabon, and A.B.-L. is recipient of a PhD fellowship from the Ministère de la Recherche et de la Technologie.